Article addresses tremendous impact of genetic testing for Alzheimer’s

| July 12, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Genetic tests exist to identify risk for the rare inherited form of early-onset Alzheimer’s disease (AD) and to predict susceptibility to the more common, late-onset form of AD, but do people want to know, and how do they react? The answers can be found in the article published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free on the Genetic Testing and Molecular Biomarkers website.

View the original article here: Article addresses tremendous impact of genetic testing for Alzheimer’s – News-Medical.Net

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend